Kao-Ping Chua
kaopingchua.bsky.social
Kao-Ping Chua
@kaopingchua.bsky.social
Primary care pediatrician and health policy researcher at the University of Michigan studying the opioid epidemic, out-of-pocket spending, low-value care, child health. Director, CHEAR Center (chear.org). MD (Wash U), PhD (Harvard). Go Lions and Go Blue
Reposted by Kao-Ping Chua
People receiving emergency care for an opioid overdose have only a 1 in 16 chance of getting medication to treat substance use disorder in ER or the month after, according to this new study led by Thuy Nguyen of @umichsph.bsky.social & @kaopingchua.bsky.social: www.healthaffairs.org/doi/full/10....
Medicaid Patients With ED Visits For Overdose: Disparities In Initiation Of Medications For Opioid Use Disorder | Health Affairs Journal
Medications for opioid use disorder (MOUD) after emergency department (ED) visits for overdose can reduce subsequent overdose deaths, but disparities in receiving MOUD persist in the US. Using nationa...
www.healthaffairs.org
May 6, 2025 at 10:49 AM
Yes, it is an important paper.
April 26, 2025 at 3:54 PM
4/ Congrats to first author Joanne Constantin for this study.
March 6, 2025 at 7:49 PM
3/ This is one of the first studies to evaluate the safety of telehealth stimulant prescribing. We hope it will inform ongoing debates about whether to extend telehealth flexibilities for controlled substance prescribing.
March 6, 2025 at 7:49 PM
2/ In subgroup analyses, telehealth initiation was associated with higher risk of SUD in 26-34 year old even when controlling for mental health conditions. Thus, while telehealth initiation is not an independent risk factor for SUD in most people, it may be for this age group.
March 6, 2025 at 7:49 PM
Reposted by Kao-Ping Chua
Alas @joyclee.bsky.social & @kaopingchua.bsky.social ‘s work documenting use of GLP-1 meds in teens and young adults was not mentioned so I’ll link it here: www.michiganmedicine.org/health-lab/y...
Young people are increasingly using Wegovy and Ozempic
A national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.
www.michiganmedicine.org
February 17, 2025 at 1:55 PM
8/ Thanks to my center (Susan B. Meister Child Health Evaluation and Research Center; chear.org) for supporting our work.
January 27, 2025 at 7:42 PM
7/ Findings suggest the shortage did not cause many children to stop stimulant therapy but may have prompted some to switch to alternative stimulants. Studies should evaluate whether these switches worsened control of ADHD symptoms or increased adverse events (e.g., from dosing errors).
January 27, 2025 at 7:42 PM
6/ However, the announcement was associated with shifts in which stimulants were dispensed to children. Specifically, it was associated with declines in Adderall IR dispensing and increases in dispensing of other stimulants, such as lisdexamfetamine.
January 27, 2025 at 7:42 PM
5/ The FDA announced a shortage of immediate-release mixed amphetamine salts (Adderall IR) in October 2022 (right vertical line). This announcement was not associated with a significant immediate change in the rate of dispensing of *any stimulant* to children.
January 27, 2025 at 7:42 PM
4/ This is consistent with our study showing that antidepressant dispensing to male adolescents dropped abruptly in March 2020 but did not recover. Our findings raise concerns that undertreatment of mental health conditions in this group has increased.
publications.aap.org/pediatrics/a...
January 27, 2025 at 7:42 PM